Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review. [PDF]
Seligman C, Chang YM, Luo J, Garden OA.
europepmc +1 more source
Amifampridine for Lambert-Eaton myasthenic syndrome. [PDF]
europepmc +1 more source
Lambert-Eaton myasthenic syndromes [PDF]
openaire +1 more source
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims data. [PDF]
Drapkin BJ +4 more
europepmc +1 more source
Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer. [PDF]
Takigawa Y +12 more
europepmc +1 more source
N-type voltage-gated calcium channel antibody testing lacks diagnostic value in Lambert-Eaton myasthenic syndrome. [PDF]
Arlt FA +10 more
europepmc +1 more source
Lambert Eaton Myasthenic Syndrome: A Bridge Diagnostic For Occult Tumor
De Moura Campos M +3 more
europepmc +1 more source
Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States. [PDF]
Ginebaugh SP +3 more
europepmc +1 more source
Amifampridines are the Most Effective Drugs for Treating Lambert-Eaton Myasthenic Syndrome With a Focus on Pediatric Lambert-Eaton Myasthenic Syndrome. [PDF]
Oh SJ.
europepmc +1 more source
Type 2 Respiratory Failure as an Initial Manifestation of Lambert-Eaton Myasthenic Syndrome Complicated by Paraneoplastic Autoimmune Encephalitis. [PDF]
Uemura S +4 more
europepmc +1 more source

